Skip to main content

Published locations for Androgen-signaling inhibitors extend survival in luminal mCRPC subtype

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Androgen-signaling inhibitors extend survival in luminal mCRPC subtype

User login

  • Reset your password
  • /content/androgen-signaling-inhibitors-extend-survival-luminal-mcrpc-subtype
  • /fedprac/article/247674/prostate-cancer/androgen-signaling-inhibitors-extend-survival-luminal-mcrpc